share_log
Reuters ·  May 6 08:02
Lyell Immunopharma Inc - Ind for Second Generation Ror1-Targeted Car T-Cell Product Candidate on Track for Submission This Quarter
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment